Mr. Basudeo N. Singh
Executive Chairman

Mr. Basudeo N. Singh has over five decades of experience in the Indian pharmaceutical industry and is also a co-founder of the Company. He holds BA (Honours) and MA in political science from Patna University. In the period extending 2007 – 2008, Mr. Singh had a stint as President of the Indian Drug Manufacturers’ Association. He was the recipient of ‘Business Leader of the Year 2014’ at the 7 th Annual Pharmaceutical Leadership Summit and the Pharma Leaders Business Leadership Awards 2014. He was also named ‘EY Entrepreneur of the Year in Life Sciences’ in the year 2016. On 20 th January 2018, he was named ‘Chief Mentor of the Year’ by the Indian Drug Manufacturers’ Association. He is also a member of the Executive Council of the Indian Pharmaceutical Alliance.

Mr. Sandeep Singh
Managing Director

Mr. Sandeep Singh joined the Board in the year 2013; currently, he is serving the organization as its Managing Director. Mr. Singh has over 18 years of experience in the pharmaceutical industry. He spearheads the domestic as well as the international operations of the organization. In the year 2016, he was presented with the ‘Emerging Pharma Leader of 2016 Award’ by the Pharma Leaders in association with the Ministry of Health & Family Affairs, Government of India. In the year 2021, he was featured by ‘ET AND SPENCER STUART 40 under 40’.

Mrs. Madhurima Singh
Executive Director

Mrs. Madhurima Singh is an Executive Director on the Board of the Company having extensive experience in the fields of Legal and Compliance, Financial Management, Human Resource, Supply Chain Management and Marketing. She holds an MSc degree in Botany (distinction) from Ranchi University and Diploma in entrepreneurship from SVKM’s, Mumbai. She has been actively involved in overseeing and managing the semi-chronic therapy SBU’s of the Company’s domestic business, manufacturing, distribution and supply chain, HR, CSR and Corporate Communications. She is additionally responsible for reviving and building Active Pharmaceutical (API) business of the Company.

Mr. Srinivas Singh
Executive Director

Mr. Srinivas Singh aged about 34 years, holds a Bachelor's Degree in Science and has over 10 years of experience in pharmaceutical industry. His key accountabilities include managing R&D projects, generics portfolio, cost optimization and saving, new product launches in Regulated Markets & Alternate Vendor Development and also ensuring risk assessment of to be launched products.

Mr. Mritunjay Kumar Singh
Executive Director

Mr. Mritunjay Kumar Singh joined the Board in the year 1988 and he has been associated with the management of the Company for a period of over 32 years. He is also the Managing Director of the Company’s subsidiary, Indchemie Health Specialities Private Limited. Mr. Mritunjay Kumar Singh heads Aura, Alphanex, Altis, Alphamax, Diabetology, Aspiria, Metabolics, Imperia, Arise, Pulmocare, Intenza, Critica and Urocare divisions of the Company’s domestic business. Additionally, he looks after the Strategy & Business Development and Procurement functions for the domestic business of the Company.

Mr. Arun Kumar Purwar
Independent Director

Mr. Arun Kumar Purwar was inducted on the Board in the year 2015. Mr. Purwar served as the Chairman of the State Bank of India and the Indian Bank Association for the periods from November 2002 to May 2006 and 2005-06 respectively. He has been the recipient of several prestigious awards such as ‘CEO of the Year’ from the Institute of Technology and Management in 2004, ‘Outstanding Achiever of the Year’ from the Indian Banks’ Association in 2004 and ‘Finance Man of the Year’ by the Bombay Management Association in 2006. He also serves as an independent director in various leading companies of power, steel, financial sector, fin-tech, engineering consultancy and film/ entertainment industries/ sectors.

Mr. Ranjal Laxmana Shenoy
Independent Director

Introduced in the Board in the year 2015, Mr. Ranjal Laxmana Shenoy has over 40 years of experience in varied industries. He held the position of Whole Time Director – Finance and Legal and Company Secretary in Merck Limited (formerly known as E. Merck (India) Limited), India. He is a qualified Chartered Accountant, Cost Accountant and Company Secretary. Mr. Shenoy also holds a Bachelor Degree in Law from the University of Mysore and a Master Degree in Law from the University of Mumbai. He is also an Associate Member of the Indian Institute of Bankers (C.A.IIB).

Mr. Narendra K Aneja
Independent Director

Mr. Narendra Kumar Aneja inducted on the Board in 2020, is the Chief Executive of Aneja Associates, Chartered Accountants, India. He is a Fellow Chartered Accountant, Certified Internal Auditor, Certification in Risk Management Assurance (CRMA) and holds an MBA from the Wharton Business School. He is a Gold Medalist (ICWA), a Tata Scholar and was ranked on the Director’s List at Wharton School (1978). He has over 30 years of experience in GRC (Governance, Risk and Compliance) Assignments and management consultancy.

Ms. Sangeeta K. Singh
Independent Director

Ms. Sangeeta Singh became a member of the Board in 2015. She serves as an Independent Director on the boards of several renowned companies. She has over 35 years of experience in Human Resources, Communications and Operations. She was previously a Partner & Head of Human Resources in KPMG India. She holds a Master Degree in Behavioural Psychology and certification in Strategic Human Resource Management from Harvard Business School.

Ms. Sudha Ravi
Independent Director

Ms. Sudha Ravi is a financial services executive with over 40 years of banking, non-banking and regulatory experience in India and USA. In the three decades in State Bank of India (SBI), she has held several important positions including key positions as General Manager, Enterprise Risk Management and as Chief Representative, Washington DC, USA. Later joining the Ajay Piramal Group, Ms. Ravi set up the NBFC- Piramal Finance Ltd and was with the Group’s Financial Services business and a healthcare and life sciences focused PE fund in various capacities including as CEO/ED/ CCO. Ms. Sudha Ravi joined the Board in 2015.

Dr. Dheeraj Sharma
Independent Director

Dr. Dheeraj Sharma joined the Board in 2017. He holds a Doctoral Degree with a Major in Marketing and a double Minor in Psychology and Quantitative Analysis from Louisiana Tech University, USA. His primary research interests are ‘relationships’ in the business domain. He is a Director at Indian Institute of Management, Rohtak. In the past, Dr. Sharma has served as a consultant or in advisory roles with Ministry of Home Affairs, Ministry of Defence, Ministry of Youth Affairs and Sports, Ministry of Commerce, Government of Gujarat, Government of Punjab and Government of Delhi.

Mr. Sujjain Talwar
Independent Director

Mr. Sujjain Talwar recently inducted on the Board is a co-founding Partner of Economic Laws Practice (ELP) a leading Tier 1 full-service law firm in India having over 25 years of experience in corporate, infrastructure, hospitality and banking & finance laws and is a qualified Solicitor in India as well as England and Wales. He has worked extensively on private sector participation initiatives in various infrastructure projects in India and abroad. His work includes infrastructure projects in the region, including Yemen, Fujairah, Djibouti and the Maldives. He also has international experience in managing public-private participation across various infrastructure sectors including water, roads, ports and airports.

Mr. Sarvesh Singh
Executive Director

Mr. Sarvesh Singh has been associated with the Company since 2011 and has over 10 years of experience in sales and marketing in the pharmaceutical industry. Mr. Sarvesh Singh heads the Pentacare and Prizma divisions of the organization’s domestic market and has been inducted on the Board in 2019.